当前位置: X-MOL 学术ACS Med. Chem. Lett. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Design and Catalyzed Activation of Tak-242 Prodrugs for Localized Inhibition of TLR4-Induced Inflammation.
ACS Medicinal Chemistry Letters ( IF 3.5 ) Pub Date : 2020-01-03 , DOI: 10.1021/acsmedchemlett.9b00518
Michael A Plunk 1 , Alyssa Alaniz 2 , Olatunde P Olademehin 1 , Thomas L Ellington 1 , Kevin L Shuford 1 , Robert R Kane 1, 2
Affiliation  

Tak-242 (resatorvid), a Toll-like Receptor 4 (TLR4) inhibitor, has been identified as a potent suppressor of innate inflammation. As a strategy to target Tak-242 to select tissue, four TLR4-inactive prodrugs were synthesized for activation via two different release mechanisms. Two nitrobenzyl Tak-242 prodrugs released the parent drug upon exposure to the exogenous enzyme nitroreductase, while the two propargyl prodrugs were converted to Tak-242 in the presence of Pd0.

中文翻译:

Tak-242前药的设计和催化活化,用于TLR4诱导的炎症的局部抑制。

Tak-242(resatorvid)是Toll样受体4(TLR4)抑制剂,已被确定为先天性炎症的有效抑制剂。作为靶向Tak-242选择组织的策略,合成了四种TLR4失活的前药,通过两种不同的释放机制进行激活。两种硝基苄基Tak-242前药在暴露于外源酶硝基还原酶后释放了母体药物,而两种炔丙基前药在Pd0存在下转化为Tak-242。
更新日期:2020-01-08
down
wechat
bug